Ming Zhao, MD, explains the background of the FOHAIC-1 study.
Ming Zhao, MD
Advertisement
Articles by Ming Zhao, MD
In an interview with Targeted Oncology™, Ming Zhao, MD, discusses the results of the FOHAIC-1 clinical trial and how it compares to HAIC-FO for the treatment of HCC.
Advertisement
Latest Updated Articles
FOHAIC-1 Study Shows Positive Results in Hepatocellular CarcinomaPublished: February 10th 2022 | Updated:
Discussing the FOHAIC-1 Study for Patients With HCCPublished: March 18th 2022 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5
